Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RedHill Biopharma ( (RDHL) ) has provided an update.
On January 27, 2026, RedHill Biopharma filed a Form 6‑K announcing an Extraordinary General Meeting of Shareholders to be held on March 5, 2026, in Tel Aviv. Shareholders and ADS holders of record as of January 23, 2026, will vote on four key proposals: granting restricted share units (RSUs) linked to ADSs to the company’s non‑executive directors, approving additional RSU awards to CEO and Chairman Dror Ben‑Asher and to Chief Commercial Officer and Director Rick D. Scruggs, and increasing the company’s authorized share capital. The board has recommended voting in favor of all proposals, signaling a push to enhance equity-based compensation for leadership while expanding the company’s capacity to issue new shares, a move that could support future financing flexibility but also has potential dilution implications for existing investors.
The most recent analyst rating on (RDHL) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on RedHill Biopharma stock, see the RDHL Stock Forecast page.
Spark’s Take on RDHL Stock
According to Spark, TipRanks’ AI Analyst, RDHL is a Neutral.
Score is held down primarily by weak financial performance (ongoing losses, negative equity, and negative operating/free cash flow). Technicals provide a partial offset with improving short-term trend and momentum, but longer-term trend and MACD remain unsupportive. Valuation impact is neutral due to missing P/E and dividend yield.
To see Spark’s full report on RDHL stock, click here.
More about RedHill Biopharma
RedHill Biopharma Ltd. is an Israel-based biopharmaceutical company focused on the development and commercialization of drugs, with its equity traded in the U.S. via American Depositary Shares (ADSs). The company’s capital structure includes a very large number of outstanding ordinary shares represented by ADSs, and it regularly utilizes U.S. capital markets, as reflected in its multiple effective registration statements on Forms S‑8 and F‑3.
Average Trading Volume: 977,437
Technical Sentiment Signal: Sell
Current Market Cap: $6.67M
See more insights into RDHL stock on TipRanks’ Stock Analysis page.